Sweeney C - Search Results

1

Association of genetic variation in tamoxifen-metabolizing enzymes with overall survival and recurrence of disease in breast cancer patients.

Nowell SA, Ahn J, Rae JM, Scheys JO, Trovato A, Sweeney C, MacLeod SL, Kadlubar FF, Ambrosone CB. Nowell SA, et al. Among authors: sweeney c. Breast Cancer Res Treat. 2005 Jun;91(3):249-58. doi: 10.1007/s10549-004-7751-x. Breast Cancer Res Treat. 2005. PMID: 15952058 Free article.

2

Association between sulfotransferase 1A1 genotype and survival of breast cancer patients receiving tamoxifen therapy.

Nowell S, Sweeney C, Winters M, Stone A, Lang NP, Hutchins LF, Kadlubar FF, Ambrosone CB. Nowell S, et al. Among authors: sweeney c. J Natl Cancer Inst. 2002 Nov 6;94(21):1635-40. doi: 10.1093/jnci/94.21.1635. J Natl Cancer Inst. 2002. PMID: 12419790

3

Association between a glutathione S-transferase A1 promoter polymorphism and survival after breast cancer treatment.

Sweeney C, Ambrosone CB, Joseph L, Stone A, Hutchins LF, Kadlubar FF, Coles BF. Sweeney C, et al. Int J Cancer. 2003 Mar 1;103(6):810-4. doi: 10.1002/ijc.10896. Int J Cancer. 2003. PMID: 12516103

4

Polymorphisms in genes related to oxidative stress (MPO, MnSOD, CAT) and survival after treatment for breast cancer.

Ambrosone CB, Ahn J, Singh KK, Rezaishiraz H, Furberg H, Sweeney C, Coles B, Trovato A. Ambrosone CB, et al. Among authors: sweeney c. Cancer Res. 2005 Feb 1;65(3):1105-11. Cancer Res. 2005. PMID: 15705913

5

Polymorphisms in glutathione S-transferases (GSTM1 and GSTT1) and survival after treatment for breast cancer.

Ambrosone CB, Sweeney C, Coles BF, Thompson PA, McClure GY, Korourian S, Fares MY, Stone A, Kadlubar FF, Hutchins LF. Ambrosone CB, et al. Among authors: sweeney c. Cancer Res. 2001 Oct 1;61(19):7130-5. Cancer Res. 2001. PMID: 11585745

6

Common genetic polymorphisms in the 5'-flanking region of the SULT1A1 gene: haplotypes and their association with platelet enzymatic activity.

Ning B, Nowell S, Sweeney C, Ambrosone CB, Williams S, Miao X, Liang G, Lin D, Stone A, Ratnasinghe DL, Manjanatha M, Lang NP, Kadlubar FF. Ning B, et al. Among authors: sweeney c. Pharmacogenet Genomics. 2005 Jul;15(7):465-73. doi: 10.1097/01.fpc.0000166823.74378.79. Pharmacogenet Genomics. 2005. PMID: 15970794

7

Association between survival after treatment for breast cancer and glutathione S-transferase P1 Ile105Val polymorphism.

Sweeney C, McClure GY, Fares MY, Stone A, Coles BF, Thompson PA, Korourian S, Hutchins LF, Kadlubar FF, Ambrosone CB. Sweeney C, et al. Cancer Res. 2000 Oct 15;60(20):5621-4. Cancer Res. 2000. PMID: 11059750

8

CYP2A6 activity determined by caffeine phenotyping: association with colorectal cancer risk.

Nowell S, Sweeney C, Hammons G, Kadlubar FF, Lang NP. Nowell S, et al. Among authors: sweeney c. Cancer Epidemiol Biomarkers Prev. 2002 Apr;11(4):377-83. Cancer Epidemiol Biomarkers Prev. 2002. PMID: 11927498

9

Novel markers of susceptibility to carcinogens in diet: associations with colorectal cancer.

Sweeney C, Coles BF, Nowell S, Lang NP, Kadlubar FF. Sweeney C, et al. Toxicology. 2002 Dec 27;181-182:83-7. doi: 10.1016/s0300-483x(02)00259-7. Toxicology. 2002. PMID: 12505289 Clinical Trial.

10

The role of human glutathione S-transferases (hGSTs) in the detoxification of the food-derived carcinogen metabolite N-acetoxy-PhIP, and the effect of a polymorphism in hGSTA1 on colorectal cancer risk.

Coles B, Nowell SA, MacLeod SL, Sweeney C, Lang NP, Kadlubar FF. Coles B, et al. Among authors: sweeney c. Mutat Res. 2001 Oct 1;482(1-2):3-10. doi: 10.1016/s0027-5107(01)00187-7. Mutat Res. 2001. PMID: 11535243

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,180 results

Search Page

Filters